The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Bispecific Antibodies Market Research Report 2025
Synopsis
A bispecific antibody (BsAb), or specific monoclonal antibody (BsMAb) is an artificial protein comprised of fragments from two different antibodies. By virtue of the inclusion of two different antigen binding regions, a bispecific antibody is capable of recognizing and binding to two different antigens, or two different epitope on an antigen.
The global Bispecific Antibodies market was valued at US$ 3266 million in 2023 and is anticipated to reach US$ 4147.6 million by 2030, witnessing a CAGR of 3.4% during the forecast period 2024-2030.
Global Bi-Specific Antibodies Therapy key players include Roche, Amgen, Sanofi, Pfizer, Johnson & Johnson, etc. Global top five manufacturers hold a share over 95%.
North America is the largest market, with a share about 65%, followed by Europe and China, both have a share over 30 percent. In terms of product, IgG-Based Antibodies is the largest segment, with a share over 85%. And in terms of application, the largest application is Haemophilia, followed by Cancer, etc.
This report aims to provide a comprehensive presentation of the global market for Bispecific Antibodies, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Bispecific Antibodies.
Report Scope
The Bispecific Antibodies market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Bispecific Antibodies market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Bispecific Antibodies companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Roche Holding AG
GenScript
Sino Biological Inc.
Creative-Biolabs
AbbVie Inc.
Kymab
AstraZeneca
BIOCYTOGEN
Amgen Inc.
Pfizer Inc.
Novartis AG
Johnson & Johnson
ProteoGenix
Segment by Type
Blinatumab
Catumaxomab
Duligotumab
Segment by Application
Cancer
Infectious Disease
Inflammatory and Autoimmune Disorders
CNS Disorders
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Bispecific Antibodies companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
A bispecific antibody (BsAb), or specific monoclonal antibody (BsMAb) is an artificial protein comprised of fragments from two different antibodies. By virtue of the inclusion of two different antigen binding regions, a bispecific antibody is capable of recognizing and binding to two different antigens, or two different epitope on an antigen.
The global Bispecific Antibodies market was valued at US$ 3266 million in 2023 and is anticipated to reach US$ 4147.6 million by 2030, witnessing a CAGR of 3.4% during the forecast period 2024-2030.
Global Bi-Specific Antibodies Therapy key players include Roche, Amgen, Sanofi, Pfizer, Johnson & Johnson, etc. Global top five manufacturers hold a share over 95%.
North America is the largest market, with a share about 65%, followed by Europe and China, both have a share over 30 percent. In terms of product, IgG-Based Antibodies is the largest segment, with a share over 85%. And in terms of application, the largest application is Haemophilia, followed by Cancer, etc.
This report aims to provide a comprehensive presentation of the global market for Bispecific Antibodies, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Bispecific Antibodies.
Report Scope
The Bispecific Antibodies market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Bispecific Antibodies market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Bispecific Antibodies companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Roche Holding AG
GenScript
Sino Biological Inc.
Creative-Biolabs
AbbVie Inc.
Kymab
AstraZeneca
BIOCYTOGEN
Amgen Inc.
Pfizer Inc.
Novartis AG
Johnson & Johnson
ProteoGenix
Segment by Type
Blinatumab
Catumaxomab
Duligotumab
Segment by Application
Cancer
Infectious Disease
Inflammatory and Autoimmune Disorders
CNS Disorders
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Bispecific Antibodies companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Bispecific Antibodies Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Blinatumab
1.2.3 Catumaxomab
1.2.4 Duligotumab
1.3 Market by Application
1.3.1 Global Bispecific Antibodies Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Cancer
1.3.3 Infectious Disease
1.3.4 Inflammatory and Autoimmune Disorders
1.3.5 CNS Disorders
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Bispecific Antibodies Market Perspective (2019-2030)
2.2 Bispecific Antibodies Growth Trends by Region
2.2.1 Global Bispecific Antibodies Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Bispecific Antibodies Historic Market Size by Region (2019-2024)
2.2.3 Bispecific Antibodies Forecasted Market Size by Region (2025-2030)
2.3 Bispecific Antibodies Market Dynamics
2.3.1 Bispecific Antibodies Industry Trends
2.3.2 Bispecific Antibodies Market Drivers
2.3.3 Bispecific Antibodies Market Challenges
2.3.4 Bispecific Antibodies Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Bispecific Antibodies Players by Revenue
3.1.1 Global Top Bispecific Antibodies Players by Revenue (2019-2024)
3.1.2 Global Bispecific Antibodies Revenue Market Share by Players (2019-2024)
3.2 Global Bispecific Antibodies Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Bispecific Antibodies Revenue
3.4 Global Bispecific Antibodies Market Concentration Ratio
3.4.1 Global Bispecific Antibodies Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Bispecific Antibodies Revenue in 2023
3.5 Bispecific Antibodies Key Players Head office and Area Served
3.6 Key Players Bispecific Antibodies Product Solution and Service
3.7 Date of Enter into Bispecific Antibodies Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Bispecific Antibodies Breakdown Data by Type
4.1 Global Bispecific Antibodies Historic Market Size by Type (2019-2024)
4.2 Global Bispecific Antibodies Forecasted Market Size by Type (2025-2030)
5 Bispecific Antibodies Breakdown Data by Application
5.1 Global Bispecific Antibodies Historic Market Size by Application (2019-2024)
5.2 Global Bispecific Antibodies Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Bispecific Antibodies Market Size (2019-2030)
6.2 North America Bispecific Antibodies Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Bispecific Antibodies Market Size by Country (2019-2024)
6.4 North America Bispecific Antibodies Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Bispecific Antibodies Market Size (2019-2030)
7.2 Europe Bispecific Antibodies Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Bispecific Antibodies Market Size by Country (2019-2024)
7.4 Europe Bispecific Antibodies Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Bispecific Antibodies Market Size (2019-2030)
8.2 Asia-Pacific Bispecific Antibodies Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Bispecific Antibodies Market Size by Region (2019-2024)
8.4 Asia-Pacific Bispecific Antibodies Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Bispecific Antibodies Market Size (2019-2030)
9.2 Latin America Bispecific Antibodies Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Bispecific Antibodies Market Size by Country (2019-2024)
9.4 Latin America Bispecific Antibodies Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Bispecific Antibodies Market Size (2019-2030)
10.2 Middle East & Africa Bispecific Antibodies Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Bispecific Antibodies Market Size by Country (2019-2024)
10.4 Middle East & Africa Bispecific Antibodies Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Roche Holding AG
11.1.1 Roche Holding AG Company Detail
11.1.2 Roche Holding AG Business Overview
11.1.3 Roche Holding AG Bispecific Antibodies Introduction
11.1.4 Roche Holding AG Revenue in Bispecific Antibodies Business (2019-2024)
11.1.5 Roche Holding AG Recent Development
11.2 GenScript
11.2.1 GenScript Company Detail
11.2.2 GenScript Business Overview
11.2.3 GenScript Bispecific Antibodies Introduction
11.2.4 GenScript Revenue in Bispecific Antibodies Business (2019-2024)
11.2.5 GenScript Recent Development
11.3 Sino Biological Inc.
11.3.1 Sino Biological Inc. Company Detail
11.3.2 Sino Biological Inc. Business Overview
11.3.3 Sino Biological Inc. Bispecific Antibodies Introduction
11.3.4 Sino Biological Inc. Revenue in Bispecific Antibodies Business (2019-2024)
11.3.5 Sino Biological Inc. Recent Development
11.4 Creative-Biolabs
11.4.1 Creative-Biolabs Company Detail
11.4.2 Creative-Biolabs Business Overview
11.4.3 Creative-Biolabs Bispecific Antibodies Introduction
11.4.4 Creative-Biolabs Revenue in Bispecific Antibodies Business (2019-2024)
11.4.5 Creative-Biolabs Recent Development
11.5 AbbVie Inc.
11.5.1 AbbVie Inc. Company Detail
11.5.2 AbbVie Inc. Business Overview
11.5.3 AbbVie Inc. Bispecific Antibodies Introduction
11.5.4 AbbVie Inc. Revenue in Bispecific Antibodies Business (2019-2024)
11.5.5 AbbVie Inc. Recent Development
11.6 Kymab
11.6.1 Kymab Company Detail
11.6.2 Kymab Business Overview
11.6.3 Kymab Bispecific Antibodies Introduction
11.6.4 Kymab Revenue in Bispecific Antibodies Business (2019-2024)
11.6.5 Kymab Recent Development
11.7 AstraZeneca
11.7.1 AstraZeneca Company Detail
11.7.2 AstraZeneca Business Overview
11.7.3 AstraZeneca Bispecific Antibodies Introduction
11.7.4 AstraZeneca Revenue in Bispecific Antibodies Business (2019-2024)
11.7.5 AstraZeneca Recent Development
11.8 BIOCYTOGEN
11.8.1 BIOCYTOGEN Company Detail
11.8.2 BIOCYTOGEN Business Overview
11.8.3 BIOCYTOGEN Bispecific Antibodies Introduction
11.8.4 BIOCYTOGEN Revenue in Bispecific Antibodies Business (2019-2024)
11.8.5 BIOCYTOGEN Recent Development
11.9 Amgen Inc.
11.9.1 Amgen Inc. Company Detail
11.9.2 Amgen Inc. Business Overview
11.9.3 Amgen Inc. Bispecific Antibodies Introduction
11.9.4 Amgen Inc. Revenue in Bispecific Antibodies Business (2019-2024)
11.9.5 Amgen Inc. Recent Development
11.10 Pfizer Inc.
11.10.1 Pfizer Inc. Company Detail
11.10.2 Pfizer Inc. Business Overview
11.10.3 Pfizer Inc. Bispecific Antibodies Introduction
11.10.4 Pfizer Inc. Revenue in Bispecific Antibodies Business (2019-2024)
11.10.5 Pfizer Inc. Recent Development
11.11 Novartis AG
11.11.1 Novartis AG Company Detail
11.11.2 Novartis AG Business Overview
11.11.3 Novartis AG Bispecific Antibodies Introduction
11.11.4 Novartis AG Revenue in Bispecific Antibodies Business (2019-2024)
11.11.5 Novartis AG Recent Development
11.12 Johnson & Johnson
11.12.1 Johnson & Johnson Company Detail
11.12.2 Johnson & Johnson Business Overview
11.12.3 Johnson & Johnson Bispecific Antibodies Introduction
11.12.4 Johnson & Johnson Revenue in Bispecific Antibodies Business (2019-2024)
11.12.5 Johnson & Johnson Recent Development
11.13 ProteoGenix
11.13.1 ProteoGenix Company Detail
11.13.2 ProteoGenix Business Overview
11.13.3 ProteoGenix Bispecific Antibodies Introduction
11.13.4 ProteoGenix Revenue in Bispecific Antibodies Business (2019-2024)
11.13.5 ProteoGenix Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Bispecific Antibodies Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Blinatumab
Table 3. Key Players of Catumaxomab
Table 4. Key Players of Duligotumab
Table 5. Global Bispecific Antibodies Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Bispecific Antibodies Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Bispecific Antibodies Market Size by Region (2019-2024) & (US$ Million)
Table 8. Global Bispecific Antibodies Market Share by Region (2019-2024)
Table 9. Global Bispecific Antibodies Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 10. Global Bispecific Antibodies Market Share by Region (2025-2030)
Table 11. Bispecific Antibodies Market Trends
Table 12. Bispecific Antibodies Market Drivers
Table 13. Bispecific Antibodies Market Challenges
Table 14. Bispecific Antibodies Market Restraints
Table 15. Global Bispecific Antibodies Revenue by Players (2019-2024) & (US$ Million)
Table 16. Global Bispecific Antibodies Market Share by Players (2019-2024)
Table 17. Global Top Bispecific Antibodies Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bispecific Antibodies as of 2023)
Table 18. Ranking of Global Top Bispecific Antibodies Companies by Revenue (US$ Million) in 2023
Table 19. Global 5 Largest Players Market Share by Bispecific Antibodies Revenue (CR5 and HHI) & (2019-2024)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Bispecific Antibodies Product Solution and Service
Table 22. Date of Enter into Bispecific Antibodies Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Bispecific Antibodies Market Size by Type (2019-2024) & (US$ Million)
Table 25. Global Bispecific Antibodies Revenue Market Share by Type (2019-2024)
Table 26. Global Bispecific Antibodies Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 27. Global Bispecific Antibodies Revenue Market Share by Type (2025-2030)
Table 28. Global Bispecific Antibodies Market Size by Application (2019-2024) & (US$ Million)
Table 29. Global Bispecific Antibodies Revenue Market Share by Application (2019-2024)
Table 30. Global Bispecific Antibodies Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 31. Global Bispecific Antibodies Revenue Market Share by Application (2025-2030)
Table 32. North America Bispecific Antibodies Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 33. North America Bispecific Antibodies Market Size by Country (2019-2024) & (US$ Million)
Table 34. North America Bispecific Antibodies Market Size by Country (2025-2030) & (US$ Million)
Table 35. Europe Bispecific Antibodies Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 36. Europe Bispecific Antibodies Market Size by Country (2019-2024) & (US$ Million)
Table 37. Europe Bispecific Antibodies Market Size by Country (2025-2030) & (US$ Million)
Table 38. Asia-Pacific Bispecific Antibodies Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 39. Asia-Pacific Bispecific Antibodies Market Size by Region (2019-2024) & (US$ Million)
Table 40. Asia-Pacific Bispecific Antibodies Market Size by Region (2025-2030) & (US$ Million)
Table 41. Latin America Bispecific Antibodies Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 42. Latin America Bispecific Antibodies Market Size by Country (2019-2024) & (US$ Million)
Table 43. Latin America Bispecific Antibodies Market Size by Country (2025-2030) & (US$ Million)
Table 44. Middle East & Africa Bispecific Antibodies Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 45. Middle East & Africa Bispecific Antibodies Market Size by Country (2019-2024) & (US$ Million)
Table 46. Middle East & Africa Bispecific Antibodies Market Size by Country (2025-2030) & (US$ Million)
Table 47. Roche Holding AG Company Detail
Table 48. Roche Holding AG Business Overview
Table 49. Roche Holding AG Bispecific Antibodies Product
Table 50. Roche Holding AG Revenue in Bispecific Antibodies Business (2019-2024) & (US$ Million)
Table 51. Roche Holding AG Recent Development
Table 52. GenScript Company Detail
Table 53. GenScript Business Overview
Table 54. GenScript Bispecific Antibodies Product
Table 55. GenScript Revenue in Bispecific Antibodies Business (2019-2024) & (US$ Million)
Table 56. GenScript Recent Development
Table 57. Sino Biological Inc. Company Detail
Table 58. Sino Biological Inc. Business Overview
Table 59. Sino Biological Inc. Bispecific Antibodies Product
Table 60. Sino Biological Inc. Revenue in Bispecific Antibodies Business (2019-2024) & (US$ Million)
Table 61. Sino Biological Inc. Recent Development
Table 62. Creative-Biolabs Company Detail
Table 63. Creative-Biolabs Business Overview
Table 64. Creative-Biolabs Bispecific Antibodies Product
Table 65. Creative-Biolabs Revenue in Bispecific Antibodies Business (2019-2024) & (US$ Million)
Table 66. Creative-Biolabs Recent Development
Table 67. AbbVie Inc. Company Detail
Table 68. AbbVie Inc. Business Overview
Table 69. AbbVie Inc. Bispecific Antibodies Product
Table 70. AbbVie Inc. Revenue in Bispecific Antibodies Business (2019-2024) & (US$ Million)
Table 71. AbbVie Inc. Recent Development
Table 72. Kymab Company Detail
Table 73. Kymab Business Overview
Table 74. Kymab Bispecific Antibodies Product
Table 75. Kymab Revenue in Bispecific Antibodies Business (2019-2024) & (US$ Million)
Table 76. Kymab Recent Development
Table 77. AstraZeneca Company Detail
Table 78. AstraZeneca Business Overview
Table 79. AstraZeneca Bispecific Antibodies Product
Table 80. AstraZeneca Revenue in Bispecific Antibodies Business (2019-2024) & (US$ Million)
Table 81. AstraZeneca Recent Development
Table 82. BIOCYTOGEN Company Detail
Table 83. BIOCYTOGEN Business Overview
Table 84. BIOCYTOGEN Bispecific Antibodies Product
Table 85. BIOCYTOGEN Revenue in Bispecific Antibodies Business (2019-2024) & (US$ Million)
Table 86. BIOCYTOGEN Recent Development
Table 87. Amgen Inc. Company Detail
Table 88. Amgen Inc. Business Overview
Table 89. Amgen Inc. Bispecific Antibodies Product
Table 90. Amgen Inc. Revenue in Bispecific Antibodies Business (2019-2024) & (US$ Million)
Table 91. Amgen Inc. Recent Development
Table 92. Pfizer Inc. Company Detail
Table 93. Pfizer Inc. Business Overview
Table 94. Pfizer Inc. Bispecific Antibodies Product
Table 95. Pfizer Inc. Revenue in Bispecific Antibodies Business (2019-2024) & (US$ Million)
Table 96. Pfizer Inc. Recent Development
Table 97. Novartis AG Company Detail
Table 98. Novartis AG Business Overview
Table 99. Novartis AG Bispecific Antibodies Product
Table 100. Novartis AG Revenue in Bispecific Antibodies Business (2019-2024) & (US$ Million)
Table 101. Novartis AG Recent Development
Table 102. Johnson & Johnson Company Detail
Table 103. Johnson & Johnson Business Overview
Table 104. Johnson & Johnson Bispecific Antibodies Product
Table 105. Johnson & Johnson Revenue in Bispecific Antibodies Business (2019-2024) & (US$ Million)
Table 106. Johnson & Johnson Recent Development
Table 107. ProteoGenix Company Detail
Table 108. ProteoGenix Business Overview
Table 109. ProteoGenix Bispecific Antibodies Product
Table 110. ProteoGenix Revenue in Bispecific Antibodies Business (2019-2024) & (US$ Million)
Table 111. ProteoGenix Recent Development
Table 112. Research Programs/Design for This Report
Table 113. Key Data Information from Secondary Sources
Table 114. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Bispecific Antibodies Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Bispecific Antibodies Market Share by Type: 2023 VS 2030
Figure 3. Blinatumab Features
Figure 4. Catumaxomab Features
Figure 5. Duligotumab Features
Figure 6. Global Bispecific Antibodies Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Bispecific Antibodies Market Share by Application: 2023 VS 2030
Figure 8. Cancer Case Studies
Figure 9. Infectious Disease Case Studies
Figure 10. Inflammatory and Autoimmune Disorders Case Studies
Figure 11. CNS Disorders Case Studies
Figure 12. Bispecific Antibodies Report Years Considered
Figure 13. Global Bispecific Antibodies Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 14. Global Bispecific Antibodies Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 15. Global Bispecific Antibodies Market Share by Region: 2023 VS 2030
Figure 16. Global Bispecific Antibodies Market Share by Players in 2023
Figure 17. Global Top Bispecific Antibodies Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bispecific Antibodies as of 2023)
Figure 18. The Top 10 and 5 Players Market Share by Bispecific Antibodies Revenue in 2023
Figure 19. North America Bispecific Antibodies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. North America Bispecific Antibodies Market Share by Country (2019-2030)
Figure 21. United States Bispecific Antibodies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Canada Bispecific Antibodies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Bispecific Antibodies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe Bispecific Antibodies Market Share by Country (2019-2030)
Figure 25. Germany Bispecific Antibodies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. France Bispecific Antibodies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. U.K. Bispecific Antibodies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Italy Bispecific Antibodies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Russia Bispecific Antibodies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Nordic Countries Bispecific Antibodies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Bispecific Antibodies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific Bispecific Antibodies Market Share by Region (2019-2030)
Figure 33. China Bispecific Antibodies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Japan Bispecific Antibodies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. South Korea Bispecific Antibodies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Southeast Asia Bispecific Antibodies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. India Bispecific Antibodies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Australia Bispecific Antibodies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Bispecific Antibodies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America Bispecific Antibodies Market Share by Country (2019-2030)
Figure 41. Mexico Bispecific Antibodies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Brazil Bispecific Antibodies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Bispecific Antibodies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa Bispecific Antibodies Market Share by Country (2019-2030)
Figure 45. Turkey Bispecific Antibodies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Saudi Arabia Bispecific Antibodies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Roche Holding AG Revenue Growth Rate in Bispecific Antibodies Business (2019-2024)
Figure 48. GenScript Revenue Growth Rate in Bispecific Antibodies Business (2019-2024)
Figure 49. Sino Biological Inc. Revenue Growth Rate in Bispecific Antibodies Business (2019-2024)
Figure 50. Creative-Biolabs Revenue Growth Rate in Bispecific Antibodies Business (2019-2024)
Figure 51. AbbVie Inc. Revenue Growth Rate in Bispecific Antibodies Business (2019-2024)
Figure 52. Kymab Revenue Growth Rate in Bispecific Antibodies Business (2019-2024)
Figure 53. AstraZeneca Revenue Growth Rate in Bispecific Antibodies Business (2019-2024)
Figure 54. BIOCYTOGEN Revenue Growth Rate in Bispecific Antibodies Business (2019-2024)
Figure 55. Amgen Inc. Revenue Growth Rate in Bispecific Antibodies Business (2019-2024)
Figure 56. Pfizer Inc. Revenue Growth Rate in Bispecific Antibodies Business (2019-2024)
Figure 57. Novartis AG Revenue Growth Rate in Bispecific Antibodies Business (2019-2024)
Figure 58. Johnson & Johnson Revenue Growth Rate in Bispecific Antibodies Business (2019-2024)
Figure 59. ProteoGenix Revenue Growth Rate in Bispecific Antibodies Business (2019-2024)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
